Sun pharma

company review session on pharmaceutical giant SunPharma

1. Company review session PRESENTED BY- MONIKA LOHIA (D-54)

2. Growing together Sun Pharmaceutical Industries Limited  ( NSE : SUNPHARMA,  BSE : 524715) is A n Indian multinational  pharmaceutical company headquartered in  Mumbai.   Manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States.

3. OVERVIEW Started as partnership firm by Mr.   Dilip Shanghavi  in 1983 in  Vapi  with just five products to treat psychiatry ailments. Cardiology products were introduced in 1987 followed by gastroenterology products in 1989. Today it is the largest chronic prescription company in India and a market leader in psychiatry, neurology, cardiology ,  orthopaedics,  ophthalmology, gastroenterology and nephrology. The 2015 acquisition of Ranbaxy  has made the company the largest pharma company in India

4. Key People

5. Creating Value

6. Leadership in key T herapeutic Areas

7. Key acquisitions

8. Key Performance Indicators

9. Spending Distribution (Geography wise)

10. Global Manufacturing Footprints

11. Share Holdings

12. Stock Market

13. Balance sheet

14. Profit and loss statement

15. Financial ratios

16. Recent News March 8, 2016 - Sun Pharma signs M S Dhoni as Revital H brand ambassador Feb 12, 2016- Sun Pharma Q3 net profit surges over 3-fold to Rs 1,417 crore Jan 29, 2016- Sun Pharmaceuticals to sell some low priority Ranbaxy brands Dec 19, 2015- U.S. FDA warns Sun Pharma over standards at Halol plant ( Gujrat ) Sep 1 2015- Sun Pharma completes acquisition of GSK Australia opiates biz

17. CONCLUSION Sun pharmaceuticals is performing well financials show that the company has huge scope of growth. After acquiring Ranbaxy it has become 5 th largest pharmaceutical company in the world. So it is recommended to invest in this company.

18. Any questions ?